Infection, inflammation, and gastrointestinal cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

28 citing papers in PubMed.

1. Astilbin ameliorates intestinal inflammation and suppresses colorectal cancer cell proliferation by regulating NLRP3 inflammasome and nuclear factor-kappa B signaling pathway.Indian journal of pharmacology · 2026
   Article
2. Mismatch Repair Protein Msh6International journal of molecular sciences · 2023
   Article
3. Systemic Diseases and Gastrointestinal Cancer Risk.Journal of cancer & allied specialties · 2023
   Review
4. Quercetin exerts anti-inflammatory effectsWorld journal of gastroenterology · 2022
   Article
5. Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.The British journal of surgery · 2018
   Review
6. Biomimetic nanoparticles for inflammation targeting.Acta pharmaceutica Sinica. B · 2018
   Review
7. Role of vitamin DBMC gastroenterology · 2016
   Article
8. A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.Journal of the National Cancer Institute · 2015
   Article
9. Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration.Stem cell reports · 2015
   Article
10. Choline and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β.Oxidative medicine and cellular longevity · 2015
    Article
11. Republished: tracing PAKs from GI inflammation to cancer.Postgraduate medical journal · 2014
    Article
12. Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (review).International journal of oncology · 2014
    Review
13. MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract.PloS one · 2014
    Article
14. Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer.Medical oncology (Northwood, London, England) · 2013
    Article
15. Vitamin B6 and colorectal cancer: current evidence and future directions.World journal of gastroenterology · 2013
    Review
16. Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC).Clinical epigenetics · 2011
    Article
17. The "Mutated in Colorectal Cancer" Protein Is a Novel Target of the UV-Induced DNA Damage Checkpoint.Genes & cancer · 2010
    Article
18. Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori.BMC cancer · 2010
    Article
19. Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis.Investigational new drugs · 2010
    Article
20. JC virus mediates invasion and migration in colorectal metastasis.PloS one · 2009
    Article

Corrections and comments

• Commented on by
  Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people.2007

Authors and funding

4 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as